---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-008343"
form_type: "8-K"
ticker: "ENSC"
cik: "0001716947"
company_name: "Ensysce Biosciences, Inc."
filed_at: "2026-02-27T23:59:59+00:00"
generated_at: "2026-05-15T23:06:56.646464+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Ensysce Biosciences receives Nasdaq deficiency notice for bid price below $1

## Summary
- Received Nasdaq deficiency letter on Feb 25, 2026; bid price closed below $1 for 30 consecutive business days.
- Company has 180 days, until August 24, 2026, to regain compliance by closing at $1 for 10 consecutive days.
- If not compliant by Aug 24, Nasdaq may grant a second 180-day period if other listing standards met.
- Company intends to monitor bid price and evaluate options; trading on Nasdaq continues under ENSC.
- Failure to regain compliance could lead to delisting, impairing capital raising and market liquidity.

## SEC filing metadata
- accession: 0001493152-26-008343
- form_type: 8-K
- ticker: ENSC
- cik: 0001716947
- company_name: Ensysce Biosciences, Inc.
- filed_at: 2026-02-27T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.75
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1716947/000149315226008343/0001493152-26-008343-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1716947/000149315226008343/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-008343
- JSON: https://secwatch.observer/filing/0001493152-26-008343.json
- Plain text: https://secwatch.observer/filing/0001493152-26-008343.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.